FREE SHIPPING ON ORDERS OVER $150

soul semaglutide Oral Reduces CV Events in T2DM – Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine πŸ§ͺ T2DM + ASCVD/CKD πŸ’Š Oral semaglutide 14 mg vs placebo πŸ“‰ Trial Scorecard: SOUL

$28.00

Quantity
- +
Description

Once I cut everything in half and ate twice as often, the nausea almost disappeared. Sarah M., 42 Mistake #2: Skipping Protein The problem: With suppressed appetite, eating becomes a chore

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

On the other hand, only a few studies clearly reported DPN rather than combining it with autonomic neuropathy

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

This is especially significant because the pharmaceutical industry is currently shifting gears

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

Racial composition was comparable, with non-Hispanic/Latino individuals making up the largest proportion in each cohort

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

95% CI, 0.38-0.85), all-cause mortality (HR = 0.25

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

Wegovy contains the same active ingredient as Ozempic, but doctors prescribe it at higher doses specifically for chronic weight management

soul semaglutide Oral Reduces CV Events in T2DM  Trial (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine  T2DM + ASCVD/CKD  Oral semaglutide 14 mg vs placebo  Trial Scorecard: SOUL

You may also like

recommand products